다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Neumora Therapeutics Inc (NMRA)
Neumora Therapeutics Inc (NMRA) 뉴스

NMRA

Neumora Therapeutics (NMRA)

Neumora Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NMRA

1

일자	시간	출처	헤드라인	심볼	기업
2024/06/15	05:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/06/15	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/05/14	20:00	GlobeNewswire Inc.	Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/05/08	05:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/05/07	20:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/05/07	20:00	GlobeNewswire Inc.	Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/05/06	20:00	GlobeNewswire Inc.	Neumora Therapeutics to Participate in Upcoming Conferences in May	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/04/15	19:30	GlobeNewswire Inc.	Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/03/13	20:00	GlobeNewswire Inc.	Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/03/08	06:34	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/03/07	21:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/03/07	21:00	GlobeNewswire Inc.	Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/02/17	06:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/02/17	06:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/02/17	06:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/02/17	06:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/01/22	21:00	GlobeNewswire Inc.	Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/01/08	22:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NMRA	Neumora Therapeutics Inc
2024/01/02	21:00	GlobeNewswire Inc.	Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/12/16	07:06	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/12/12	21:00	GlobeNewswire Inc.	Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/11/29	06:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/11/27	21:00	GlobeNewswire Inc.	Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/11/02	05:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/11/02	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/11/01	20:00	GlobeNewswire Inc.	Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/10/30	20:00	GlobeNewswire Inc.	Neumora Therapeutics to Participate in Upcoming Conferences in November	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/10/10	20:00	GlobeNewswire Inc.	Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/09/20	07:51	KR Market News	인스타카트, 나스닥 데뷔로 주가는 12% 상승	NASDAQ:NMRA	Neumora Therapeutics Inc
2023/09/15	09:49	GlobeNewswire Inc.	Neumora Therapeutics Announces Pricing of Initial Public Offering	NASDAQ:NMRA	Neumora Therapeutics Inc

검색 관련기사 보기:NASDAQ:NMRA

1

JP Morgan Chase

Invesco QQQ Trust Series 1

BNP Paribas (QX)

Deutsche Telekom (QX)

Bank of America

Health Care Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관